Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
about
Acupuncture for psoriasis: protocol for a systematic reviewAdverse drug reactions in dermatology.Human autoimmune diseases: a comprehensive update.The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.The role of IL-17 in the treatment of psoriatic arthritis.Current treatment options for psoriatic arthritis: spotlight on abatacept.
P2860
Q28082927-4CFCAA46-5888-4DDB-9751-57F08A3BC06EQ38333021-FF60FF21-8D18-40ED-BE32-B53BE700D167Q38554722-4FD9987D-3B46-492B-AF55-04B0B7DF0CBFQ38612964-147854F9-F262-41A7-B1BD-CC532CFB7DDBQ38816194-3BB81ABE-1A0B-4D0F-8224-C13C7989266DQ39293096-ED2D37BD-DC4F-405C-91CF-0178AC7C5A3AQ55318901-E061E8B2-5E01-48A1-A998-B38F99054DC8
P2860
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
@en
type
label
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
@en
prefLabel
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
@en
P2093
P2860
P356
P1476
Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis.
@en
P2093
P2860
P304
P356
10.1111/CED.12390
P577
2014-08-01T00:00:00Z